These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3664426)

  • 1. Hormonal treatment of advanced breast cancer. A randomized trial of tamoxifen versus nandrolone decanoate.
    Kellokumpu-Lehtinen P; Huovinen R; Johansson R
    Cancer; 1987 Nov; 60(10):2376-81. PubMed ID: 3664426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nandrolone decanoate added to tamoxifen in the treatment of advanced breast cancer.
    Heinonen E; Alanko A; Gröhn P; Rissanen P
    Breast Cancer Res Treat; 1985; 5(1):75-80. PubMed ID: 3978249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral high-dose medroxyprogesterone acetate versus tamoxifen. A randomized crossover trial in postmenopausal patients with advanced breast cancer.
    van Veelen H; Willemse PH; Tjabbes T; Schweitzer MJ; Sleijfer DT
    Cancer; 1986 Jul; 58(1):7-13. PubMed ID: 2939943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of nandrolone decanoate on weight loss in advanced non-small cell lung cancer.
    Chlebowski RT; Herrold J; Ali I; Oktay E; Chlebowski JS; Ponce AT; Heber D; Block JB
    Cancer; 1986 Jul; 58(1):183-6. PubMed ID: 3518910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medroxyprogesterone acetate addition or substitution for tamoxifen in advanced tamoxifen-resistant breast cancer: a phase III randomized trial. Australian-New Zealand Breast Cancer Trials Group.
    Byrne MJ; Gebski V; Forbes J; Tattersall MH; Simes RJ; Coates AS; Dewar J; Lunn M; Flower C; Gill PG; Stewart J
    J Clin Oncol; 1997 Sep; 15(9):3141-8. PubMed ID: 9294477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of toremifene and tamoxifen in post-menopausal patients with advanced breast cancer: a randomized double-blind, the 'nordic' phase III study.
    Pyrhönen S; Valavaara R; Modig H; Pawlicki M; Pienkowski T; Gundersen S; Bauer J; Westman G; Lundgren S; Blanco G; Mella O; Nilsson I; Hietanen T; Hindy I; Vuorinen J; Hajba A
    Br J Cancer; 1997; 76(2):270-7. PubMed ID: 9231932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination hormonal therapy with tamoxifen plus fluoxymesterone versus tamoxifen alone in postmenopausal women with metastatic breast cancer. An updated analysis.
    Ingle JN; Twito DI; Schaid DJ; Cullinan SA; Krook JE; Mailliard JA; Tschetter LK; Long HJ; Gerstner JG; Windschitl HE
    Cancer; 1991 Feb; 67(4):886-91. PubMed ID: 1991261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized clinical trial of tamoxifen alone or combined with fluoxymesterone in postmenopausal women with metastatic breast cancer.
    Ingle JN; Twito DI; Schaid DJ; Cullinan SA; Krook JE; Mailliard JA; Marschke RF; Long HJ; Gerstner JG; Windschitl HE
    J Clin Oncol; 1988 May; 6(5):825-31. PubMed ID: 3284975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A controlled trial of nandrolone decanoate in the treatment of rheumatoid arthritis in postmenopausal women.
    Bird HA; Burkinshaw L; Pearson D; Atkinson PJ; Leatham PA; Hill J; Raven A; Wright V
    Ann Rheum Dis; 1987 Mar; 46(3):237-43. PubMed ID: 3555359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with tamoxifen and progestins for metastatic breast cancer in postmenopausal women: a quantitative review of published randomized clinical trials.
    Parazzini F; Colli E; Scatigna M; Tozzi L
    Oncology; 1993; 50(6):483-9. PubMed ID: 8233291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized comparison of tamoxifen and two separate doses of toremifene in postmenopausal patients with metastatic breast cancer.
    Hayes DF; Van Zyl JA; Hacking A; Goedhals L; Bezwoda WR; Mailliard JA; Jones SE; Vogel CL; Berris RF; Shemano I
    J Clin Oncol; 1995 Oct; 13(10):2556-66. PubMed ID: 7595707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tamoxifen alone versus tamoxifen plus 1-(2-tetrahydrofuryl)-5-fluorouracil in the treatment of advanced breast cancer: a sequential trial.
    Wada T; Koyama H; Terasawa T
    Breast Cancer Res Treat; 1981; 1(1):53-8. PubMed ID: 6816315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II evaluation of interferon added to tamoxifen in the treatment of metastatic breast cancer.
    Macheledt JE; Buzdar AU; Hortobagyi GN; Frye DK; Gutterman JU; Holmes FA
    Breast Cancer Res Treat; 1991 Aug; 18(3):165-70. PubMed ID: 1756259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind trial of tamoxifen plus prednisolone versus tamoxifen plus placebo in postmenopausal women with metastatic breast cancer. A collaborative trial of the North Central Cancer Treatment Group and Mayo Clinic.
    Ingle JN; Mailliard JA; Schaid DJ; Krook JE; Gesme DH; Windschitl HE; Pfeifle DM; Etzell PS; Gerstner JG; Long HJ
    Cancer; 1991 Jul; 68(1):34-9. PubMed ID: 2049750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nutritional effect of nandrolone decanoate in predialysis patients with chronic kidney disease.
    Eiam-Ong S; Buranaosot S; Eiam-Ong S; Wathanavaha A; Pansin P
    J Ren Nutr; 2007 May; 17(3):173-8. PubMed ID: 17462549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress report on two clinical trials in women with advanced breast cancer. Trial I: tamoxifen versus tamoxifen plus aminoglutethimide. Trial II: aminoglutethimide in patients with prior tamoxifen exposure.
    Ingle JN; Green SJ; Ahmann DL; Edmonson JH; Nichols WC; Frytak S; Rubin J
    Cancer Res; 1982 Aug; 42(8 Suppl):3461s-3467s. PubMed ID: 7044529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial of tamoxifen alone or combined with fluoxymesterone as adjuvant therapy in postmenopausal women with resected estrogen receptor positive breast cancer. North Central Cancer Treatment Group Trial 89-30-52.
    Ingle JN; Suman VJ; Mailliard JA; Kugler JW; Krook JE; Michalak JC; Pisansky TM; Wold LE; Donohue JH; Goetz MP; Perez EA
    Breast Cancer Res Treat; 2006 Jul; 98(2):217-22. PubMed ID: 16538529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the selective aromatase inhibitor formestane with tamoxifen as first-line hormonal therapy in postmenopausal women with advanced breast cancer.
    Pérez Carrión R; Alberola Candel V; Calabresi F; Michel RT; Santos R; Delozier T; Goss P; Mauriac L; Feuilhade F; Freue M
    Ann Oncol; 1994; 5 Suppl 7():S19-24. PubMed ID: 7873457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial of tamoxifen versus combined tamoxifen and octreotide LAR Therapy in the adjuvant treatment of early-stage breast cancer in postmenopausal women: NCIC CTG MA.14.
    Pritchard KI; Shepherd LE; Chapman JA; Norris BD; Cantin J; Goss PE; Dent SF; Walde D; Vandenberg TA; Findlay B; O'Reilly SE; Wilson CF; Han L; Piura E; Whelan TJ; Pollak MN
    J Clin Oncol; 2011 Oct; 29(29):3869-76. PubMed ID: 21911723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Results of phase II clinical trial of Tamoxifen and Toremifen in two different doses in advanced breast cancer in postmenopausal women].
    Gershanovich ML; Garin AM; Baltinia D; Kurvet A; Kangas L; Ellmen Iu
    Vopr Onkol; 1997; 43(6):587-95. PubMed ID: 9479357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.